Brief Article
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Nov 28, 2009; 15(44): 5592-5597
Published online Nov 28, 2009. doi: 10.3748/wjg.15.5592
Table 1 The demography of HCC patients and cancer-free healthy controls from Taiwan n (%)
Characteristics1Cases (58)Controls (138)P value
Age (yr)
mean65.9040.20< 0.0001
SD10.1415.24
Gender
Male45 (77.6)42 (30.2)< 0.0001
Female13 (22.4)96 (69.8)
Hepatitis
Yes49 (84.5)10 (7.2)< 0.0001
No9 (15.5)79 (57.25)
Unknown049 (35.5)
HBV2
+29100.0002
-2840
HCV3
+200< 0.0001
-3750
Alcohol intake
Yes26 (44.8)81 (58.7)0.0851
No32 (55.2)57 (41.3)
Cardiovascular diseases and/or disorders
Yes23 (39.7)26 (18.7)0.0035
No35 (59.6)116 (81.3)
BMI22.7 ± 3.1322.59 ± 3.440.8341
Table 2 The risk evaluation of MDM2 SNP309 genotypic frequencies on the development of HCC n (%)
SNP309CasesControlsOR (95% CI)1P value
TT11 (19)35 (25.3)1
TG37 (63.8)80 (58)1.016 (0.152-6.8)0.99
GG10 (17.2)23 (16.7)1.265 (0.074-21.767)0.87
TG+GG47 (81)103 (57.5)1.037 (0.757-6.862)0.97
TT+TG48 (82.8)115 (83.3)1
GG10 (17.2)23 (16.7)1.25 (0.123-12.66)0.85
Table 3 Estimation of odds ratio for different genotypes of MDM2-SNP309 in hepatitis viral infected patients with HCC n (%)
Hepatitis1SNP309CasesControlsOR295% CIP value
PositiveTT7 (14.3)1 (10)1.000
TG32 (65.3)7 (70)2.3400.11-49.6550.59
GG10 (20.4)2 (20)2.5680.054-121.6870.63
TG+GG42 (85.7)9 (90)2.3760.115-48.8960.57
NegativeTT4 (44.4)19 (24)1.000
TG5 (55.6)45 (57)0.5120.046-5.7120.59
GG3 0 (0)15 (19)---
TG+GG5 (55.6)60 (76)0.4700.041-5.3870.54